These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32886783)

  • 1. Can a Recently Developed Pig Model Be Used for In Vivo Metabolism Studies of 7-Azaindole-Derived Synthetic Cannabinoids? A Study Using 5F-MDMB-P7AICA.
    Doerr AA; Nordmeier F; Walle N; Laschke MW; Menger MD; Schmidt PH; Schaefer N; Meyer MR
    J Anal Toxicol; 2021 Jul; 45(6):593-604. PubMed ID: 32886783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of in vitro and in vivo models for the elucidation of metabolic patterns of 7-azaindole-derived synthetic cannabinoids exemplified using cumyl-5F-P7AICA.
    Walle N; Nordmeier F; Doerr AA; Peters B; Laschke MW; Menger MD; Schmidt PH; Meyer MR; Schaefer N
    Drug Test Anal; 2021 Jan; 13(1):74-90. PubMed ID: 32678962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and phase I metabolism of the 7-azaindole-derived synthetic cannabinoid 5F-AB-P7AICA including a preliminary pharmacokinetic evaluation.
    Giorgetti A; Mogler L; Haschimi B; Halter S; Franz F; Westphal F; Fischmann S; Riedel J; Pütz M; Auwärter V
    Drug Test Anal; 2020 Jan; 12(1):78-91. PubMed ID: 31476105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in 'legal high' products and human urine samples.
    Mogler L; Franz F; Rentsch D; Angerer V; Weinfurtner G; Longworth M; Banister SD; Kassiou M; Moosmann B; Auwärter V
    Drug Test Anal; 2018 Jan; 10(1):196-205. PubMed ID: 28371476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of urinary metabolites of the synthetic cannabinoid 5F-CUMYL-P7AICA in human casework.
    Staeheli SN; Steuer AE; Kraemer T
    Forensic Sci Int; 2019 Jan; 294():76-79. PubMed ID: 30471536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does a postmortem redistribution affect the concentrations of the 7 azaindole-derived synthetic cannabinoid 5F-MDMB-P7AICA in tissues and body fluids following pulmonary administration to pigs?
    Doerr AA; Nordmeier F; Walle N; Laschke MW; Menger MD; Meyer MR; Schmidt PH; Schaefer N
    Arch Toxicol; 2024 Jul; ():. PubMed ID: 38955864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic profiling of synthetic cannabinoid 5F-ADB by human liver microsome incubations and urine samples using high-resolution mass spectrometry.
    Yeter O; Ozturk YE
    Drug Test Anal; 2019 Jun; 11(6):847-858. PubMed ID: 30610752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic fate of the new synthetic cannabinoid 7'N-5F-ADB in rat, human, and pooled human S9 studied by means of hyphenated high-resolution mass spectrometry.
    Richter LHJ; Maurer HH; Meyer MR
    Drug Test Anal; 2019 Feb; 11(2):305-317. PubMed ID: 30160067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro metabolism of the synthetic cannabinoids CUMYL-PINACA, 5F-CUMYL-PINACA, CUMYL-4CN-BINACA, 5F-CUMYL-P7AICA and CUMYL-4CN-B7AICA.
    Staeheli SN; Poetzsch M; Veloso VP; Bovens M; Bissig C; Steuer AE; Kraemer T
    Drug Test Anal; 2018 Jan; 10(1):148-157. PubMed ID: 28885775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro Phase I metabolism of indazole carboxamide synthetic cannabinoid MDMB-CHMINACA via human liver microsome incubation and high-resolution mass spectrometry.
    Presley BC; Logan BK; Jansen-Varnum SA
    Drug Test Anal; 2019 Aug; 11(8):1264-1276. PubMed ID: 31108568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Studies on Temperature-Dependent In Vitro Stability during Storage and Smoking of the Synthetic Cannabinoid 5F-MDMB-P7AICA.
    Walle N; Doerr AA; Laschke MW; Menger MD; Meyer MR; Schmidt PH; Schaefer N
    J Anal Toxicol; 2022 Apr; 46(4):374-382. PubMed ID: 33629711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Going deeper into the toxicokinetics of synthetic cannabinoids: in vitro contribution of human carboxylesterases.
    Wagmann L; Stiller RG; Fischmann S; Westphal F; Meyer MR
    Arch Toxicol; 2022 Oct; 96(10):2755-2766. PubMed ID: 35788413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I metabolism of the carbazole-derived synthetic cannabinoids EG-018, EG-2201, and MDMB-CHMCZCA and detection in human urine samples.
    Mogler L; Franz F; Wilde M; Huppertz LM; Halter S; Angerer V; Moosmann B; Auwärter V
    Drug Test Anal; 2018 Sep; 10(9):1417-1429. PubMed ID: 29726116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Flying high?'-Jump from a height in a 'Spice' high?: A case report on the synthetic cannabinoid 5F-MDMB-P7AICA.
    Walle N; Doerr AA; Schmidt PH; Schaefer N
    Drug Test Anal; 2023 Mar; 15(3):368-373. PubMed ID: 36415074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methyl (S)-2-(1-7 (5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (5F-MDMB-PICA) intoxication in a child with identification of two new metabolites (ultra-high-performance liquid chromatography-tandem mass spectrometry).
    Szpot P; Nowak K; Wachełko O; Tusiewicz K; Chłopaś-Konowałek A; Zawadzki M
    Forensic Toxicol; 2023 Jan; 41(1):47-58. PubMed ID: 36652054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I metabolic profiling of the synthetic cannabinoids THJ-018 and THJ-2201 in human urine in comparison to human liver microsome and cytochrome P450 isoenzyme incubation.
    Gaunitz F; Thomas A; Fietzke M; Franz F; Auwärter V; Thevis M; Mercer-Chalmers-Bender K
    Int J Legal Med; 2019 Jul; 133(4):1049-1064. PubMed ID: 30564916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5F-MDMB-PICA metabolite identification and cannabinoid receptor activity.
    Truver MT; Watanabe S; Åstrand A; Vikingsson S; Green H; Swortwood MJ; Kronstrand R
    Drug Test Anal; 2020 Jan; 12(1):127-135. PubMed ID: 31461219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic profiling of new synthetic cannabinoids AMB and 5F-AMB by human hepatocyte and liver microsome incubations and high-resolution mass spectrometry.
    Andersson M; Diao X; Wohlfarth A; Scheidweiler KB; Huestis MA
    Rapid Commun Mass Spectrom; 2016 Apr; 30(8):1067-78. PubMed ID: 27003044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity, metabolism, and isozyme mapping of the synthetic cannabinoids JWH-200, A-796260, and 5F-EMB-PINACA studied by means of in vitro systems.
    Gampfer TM; Wagmann L; Belkacemi A; Flockerzi V; Meyer MR
    Arch Toxicol; 2021 Nov; 95(11):3539-3557. PubMed ID: 34453555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosing intake and rationalizing toxicities associated with 5F-MDMB-PINACA and 4F-MDMB-BINACA abuse.
    Lie W; Cheong EJY; Goh EML; Moy HY; Cannaert A; Stove CP; Chan ECY
    Arch Toxicol; 2021 Feb; 95(2):489-508. PubMed ID: 33236189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.